- Balminil® DM is used for suppression of a dry, hacking cough.
|Bottle 250 mL|
Dosage/Directions for Use
Adults and children 12 years and over: 2 teaspoonfuls (10 mL) every 6 to 8 hours.
Children 6 to 11 years: 1 teaspoonful (5 mL) every 6 to 8 hours.
Children 2 to 5 years: 1/2 teaspoonful (2.5 mL) every 6 to 8 hours.
Important: The maximum recommended dose is 4 times a day.
Store between 15°C and 30°C.
Protect from freezing.
KEEP OUT OF REACH OF CHILDREN.
FD&C Red #3, Hydroxypropylmethylcellulose, Magnesium
Do not exceed recommended dosage.
Before prescribing medication to suppress or modify cough, it is important to ascertain that the underlying cause of the cough is identified, that modification of the cough does not increase the risk of clinical or physiologic complications, and that appropriate therapy for the primary disease is provided.
This preparation should not be administered to children under 2 years of age, except on advice of a physician.
If this medicine causes drowsiness, reduce dosage and avoid activities requiring alertness.
If you have high blood pressure, heart or thyroid disease, diabetes, chronic alcoholism, serious liver or kidney disease, asthma, chronic lung disease/shortness of breath, persistent/chronic cough, glaucoma or difficulty in urination due to an enlargement of the prostate gland, or if you are elderly, pregnant or breast-feeding or taking a drug for depression, including monoamine oxidase (MAO) inhibitor drugs, consult a physician before using this product.
Do not take with alcoholic beverages.
If symptoms worsen, last for more than 1 week, or are accompanied by a fever or excessive secretions, consult a physician.
Caution should be exercised and dosage may need to be reduced when a dextromethorphan-containing product is administered with other drugs which depress the CNS (including alcohol), phenothiazines or tricyclic antidepressants.
Dextromethorphan is not recommended for patients with asthma unless directed by a physician.
All information about raw materials and / or allergen information for Teva Canada’s products is obtained from our suppliers and/or third party affiliates and is based on their records.
Please be advised that the Medical Information department is not always notified of change in third party affiliates and / or change in suppliers of the excipients that may occur over time, and all information provided herein is based on our last current records.
"Latex" – refers to NATURAL RUBBER LATEX. We cannot guarantee that there is no latex in the outer packaging or that the medication or packaging haven’t come into contact with latex at any point during the manufacturing process, however this is very unlikely due to the strict GMP procedures that are in place in all of our manufacturing facilities. Employees in the manufacturing and / or packaging facilities may be wearing latex gloves